RxDoctor Payments Data

Richard Mitteer, PA

Medical · Chester, PANPI 1003370347

Payments from drug & device makers

$1,600in general payments, 2019–2025

Across 85 payments — averaging $18.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$579
  • Gilead$300
  • Indivior Inc.$134
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$134
  • Otsuka America Pharmaceutical, Inc.$127
  • Teva Pharmaceuticals USA, Inc.$98
  • plus $228 from 5 others

What the payments were for

  • Food & beverage$1,54497%
  • Education$563%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,600 in reported general payments places this provider in the 75th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$3,199
Medicare patients
14
Services billed
64

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala20$69,845
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl185$42,438
BrixadiBuprenorphine25$41,627
SublocadeBuprenorphine16$32,329
SuboxoneBuprenorphine Hcl/Naloxone Hcl31$15,228
TrulicityDulaglutide13$12,780
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,147
Breo ElliptaFluticasone/Vilanterol11$4,435
Gabapentin93$1,386
Quetiapine Fumarate33$1,341
Pregabalin13$1,259
Omeprazole19$381
Bupropion XlBupropion Hcl15$316
Ibuprofen16$236
Atorvastatin Calcium43$221

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy$300$69,84520 claims
Indivior Inc.Sublocade, Suboxone$134$47,55747 claims
Hikma Pharmaceuticals USABuprenorphine-Naloxone$56$42,438185 claims
Braeburn Inc.Brixadi$91$41,62725 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Chester

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →